{"data":[{"accessionNo":"0002100119-26-001682","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences Inc","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":1923614,"percentOfClass":4.82,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"DOMA2 LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"The John Templeton Foundation","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"Pedro Escudero","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"DOMA Perpetual Partners GP LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"DOMA Perpetual LO Equity Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"Doma Perpetual Capital Management LLC","reportingCik":"0001962221","personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001104659-26-115589","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-08","reportingPerson":"DOMA1 LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0000093751-26-000517","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001396814","issuerName":"PACIRA BIOSCIENCES INC","ticker":"PCRX","cusip":"695127100","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":2059977,"percentOfClass":5.2,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0002100121-26-000856","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001396814","issuerName":"Pacira BioSciences Inc","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":2585964,"percentOfClass":6.38,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0002100119-26-001293","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001396814","issuerName":"Pacira BioSciences Inc","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":2088291,"percentOfClass":5.15,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0000354204-26-000569","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001396814","issuerName":"Pacira BioSciences Inc","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Dimensional Fund Advisors LP","reportingCik":null,"personType":"IA","sharesOwned":2060597,"percentOfClass":5.1,"filedAt":"2026-04-09","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0000102909-26-002087","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001396814","issuerName":"Pacira BioSciences Inc","ticker":"PCRX","cusip":"695127100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"Pedro Escudero","reportingCik":null,"personType":"IN","sharesOwned":2936794,"percentOfClass":7.3,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"DOMA1 LLC","reportingCik":null,"personType":"OO","sharesOwned":2777794,"percentOfClass":6.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"DOMA PERPETUAL CAPITAL MANAGEMENT LLC","reportingCik":"0001962221","personType":"IA","sharesOwned":2777794,"percentOfClass":6.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"DOMA Perpetual LO Equity Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":1965775,"percentOfClass":4.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"DOMA2 LLC","reportingCik":null,"personType":"OO","sharesOwned":1965775,"percentOfClass":4.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"DOMA Perpetual Partners GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1965775,"percentOfClass":4.9,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"The John Templeton Foundation","reportingCik":null,"personType":"CO","sharesOwned":812019,"percentOfClass":2,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001011438-26-000180","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-11","reportingPerson":"Eric de Armas","reportingCik":null,"personType":"IN","sharesOwned":1389,"percentOfClass":0,"filedAt":"2026-03-12","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"Pedro Escudero","reportingCik":null,"personType":"IN","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"Doma Perpetual Capital Management LLC","reportingCik":"0001962221","personType":"IA","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"DOMA Perpetual LO Equity Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"Doma Perpetual Partners GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"DOMA2 LLC","reportingCik":null,"personType":"OO","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-26-000011","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-30","reportingPerson":"John Templeton Foundation","reportingCik":null,"personType":"CO","sharesOwned":812019,"percentOfClass":1.89,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001037389-25-000077","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-01","reportingPerson":"Renaissance Technologies LLC","reportingCik":null,"personType":"IA","sharesOwned":2138201,"percentOfClass":4.98,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001037389-25-000077","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-01","reportingPerson":"Renaissance Technologies Holdings Corporation","reportingCik":null,"personType":"HC","sharesOwned":2138201,"percentOfClass":4.98,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"Doma Perpetual Partners GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"Pedro Escudero","reportingCik":null,"personType":"IN","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"DOMA Perpetual LO Equity Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"Doma Perpetual Capital Management LLC","reportingCik":"0001962221","personType":"IA","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"DOMA2 LLC","reportingCik":null,"personType":"OO","sharesOwned":2936794,"percentOfClass":6.83,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"},{"accessionNo":"0001214659-25-016174","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001396814","issuerName":"Pacira BioSciences, Inc.","ticker":"PCRX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-06","reportingPerson":"John Templeton Foundation","reportingCik":null,"personType":"CO","sharesOwned":812019,"percentOfClass":1.89,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx"}],"updatedAt":"2026-11-05T13:42:19.447Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pcrx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}